Sex hormones, which are known to influence UGT1A1 activity [46], and differences in UGT1A1 expression between men and women, leading to differential circulating levels [47], might partly explain the sex differences in pancreatic cancer risk. Here, UGT1A1 is linked to familial pancreatic carcinoma.